Baimakhanov Zhassulan, Kaniev Shokan, Doskhanov Maksat, Sadykov Chingiz, Serikuly Erbol, Skakbayev Aidar, Ilyassova Bibigul, Baiguissova Dinara, Seisembaev Manas, Chormanov Almat, Baimakhanov Bolatbek
Department of HPB Surgery and Liver Transplantation, Syzganov's National Scientific Center of Surgery, Almaty, Kazakhstan.
Department of HPB Surgery and Liver Transplantation, Syzganov's National Scientific Center of Surgery, Almaty, Kazakhstan.
Transplant Proc. 2019 Dec;51(10):3360-3363. doi: 10.1016/j.transproceed.2019.07.023. Epub 2019 Nov 14.
Liver transplantation has been performed in Kazakhstan since 2011. The present study aimed to analyze the outcomes of the most experienced liver transplant center in Kazakhstan.
Between December 2011 and December 2018, 131 liver transplantations were performed at A.N. Syzganov's National Scientific Center of Surgery. The clinical data of 88 adult patients who underwent living donor liver transplantations from December 2011 to December 2017 were analyzed. The patients were divided into 2 cohorts based on the periods in which the procedure was performed: the early era (2011-2014; n = 25) and the late era (2015-2017; n = 63). The clinical course and outcomes were retrospectively reviewed.
There were significant differences in the characteristics of the recipients. The patients who were treated during the late era had significantly better survival rates compared with the early era (1 year, 90.5%; 3 year, 79.6%; vs 1 year, 67.7%; 3 year 63.3%; P < .05). Right lobe grafts were used significantly more frequently during the late era (P < .05), while splenectomy was indicated significantly less frequently (P < .05). We also noted a decrease in the complication rate, including early postoperative mortality (P < .05).
Over the past 7 years, the liver transplant program has been established, and the operative techniques used in living donor liver transplant have changed dramatically. Patient survival has been improving with increased experience.
自2011年起哈萨克斯坦开始开展肝移植手术。本研究旨在分析哈萨克斯坦最具经验的肝移植中心的手术结果。
2011年12月至2018年12月期间,A.N. 瑟兹加诺夫国家外科科学中心共进行了131例肝移植手术。对2011年12月至2017年12月期间接受活体肝移植的88例成年患者的临床资料进行分析。根据手术实施时间将患者分为2组:早期(2011 - 2014年;n = 25)和晚期(2015 - 2017年;n = 63)。对临床病程和结果进行回顾性分析。
受者特征存在显著差异。与早期相比,晚期接受治疗的患者生存率显著更高(1年生存率,90.5%;3年生存率,79.6%;相比之下,早期1年生存率为67.7%;3年生存率为63.3%;P < 0.05)。晚期右叶移植的使用频率显著更高(P < 0.05),而脾切除术的实施频率显著更低(P < 0.05)。我们还注意到并发症发生率有所下降,包括术后早期死亡率(P < 0.05)。
在过去7年中,肝移植项目已建立,活体肝移植所采用的手术技术发生了显著变化。随着经验的增加,患者生存率不断提高。